In primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL), the PD-1/PD-L1 signaling pathway plays an important role in the immune microenvironment, which correlates with increased sensitivity to chemotherapy and OS. This evidence concerns the gene PDCD1 and diffuse large B-cell lymphoma.